Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Muthurangu, Vivek ^a   Atkinson, David ^a   Sermesant, Maxime ^a   Miquel, Marc E ^a   Hegde, Sanjeet ^a   Johnson, Robert ^a   Andriantsimiavona, Rado ^a   Taylor, Andrew M ^a,c   Baker, Edward ^b   Tulloh, Robert ^b   Hill, Derek ^a   Razavi, Reza S ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Magnetic resonance imaging; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADULT; ARTERY CATHETERIZATION; ARTERY COMPLIANCE; ARTICLE; CHILD; CLINICAL ARTICLE; HEART CATHETERIZATION; HEMODYNAMIC PARAMETERS; HUMAN; IMAGING SYSTEM; LUNG ARTERY; LUNG ARTERY PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; CHILD; COMPLIANCE; FEASIBILITY STUDIES; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MANOMETRY; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY WEDGE PRESSURE;

EID: 23944496582     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00957.2004     Document Type: Article

References (30)

1. Atz AM, Adatia I, Lock JE, and Wessel DL. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol 33: 813-819, 1999.
2. Atz AM and Simsic JM. Inhaled nitric oxide for pulmonary hypertension in patients with and without congenital heart disease: just say no! J S C Med Assoc 95: 349-351, 1999.
3. Beerbaum P, Korperich H, Barth P, Esdorn H, Gieseke J, and Meyer H. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation 103: 2476-2482, 2001.
4. Beerbaum P, Korperich H, Gieseke J, Barth P, Peuster M, and Meyer H. Rapid left-to-right shunt quantification in children by phase-contrast magnetic resonance imaging combined with sensitivity encoding (SENSE). Circulation 108: 1355-1361, 2003.
5. Berger RM. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 21: 17-27, 2000.
6. Berger RM, Cromme-Dijkhuis AH, Hop WC, Kruit MN, and Hess J. Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: an indicator for pulmonary vascular disease? Chest 122: 549-557, 2002.
7. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986.
8. Chemla D, Antony I, Lecarpentier Y, and Nitenberg A. Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Physiol Heart Circ Physiol 285: H614-H620, 2003.
9. Chemla D, Castelain V, Herve P, Lecarpentier Y, and Brimioulle S. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20: 1314-1331, 2002.
10. s ratio. Am J Cardiol 64: 246-247, 1989.
11. Cigarroa RG, Lange RA, Williams RH, Bedotto JB, and Hillis LD. Underestimation of cardiac output by thermodilution in patients with tricuspid regurgitation. Am J Med 86: 417-420, 1989.
12. Hampl V, Huang JM, Weir EK, and Archer SL. Activation of the cGMP-dependent protein kinase mimics the stimulatory effect of nitric oxide and cGMP on calcium-gated potassium channels. Physiol Res 44: 39-44, 1995.
13. Hopkins N and McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 201: 335-348, 2002.
14. Huez S, Brimioulle S, Naeije R, and Vachiery JL. Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. Chest 125: 2121-2128, 2004.
15. Laskey WK, Ferrari VA, Palevsky HI, and Kussmaul WG. Pulmonary artery hemodynamics in primary pulmonary hypertension. J Am Coll Cardiol 21: 406-412, 1993.
16. Liu Z, Brin KP, and Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol Heart Circ Physiol 251: H588-H600, 1986.
17. Miquel ME, Hegde S, Muthurangu V, Corcoran BJ, Keevil SF, Hill DL, and Razavi RS. Visualization and tracking of an inflatable balloon catheter using SSFP in a flow phantom and in the heart and great vessels of patients. Magn Reson Med 51: 988-995, 2004.
18. Muthurangu V, Taylor AM, Andriantsimiavona R, Hegde S, Miquel ME, Tulloh R, Baker E, Hill DL, and Razavi R. Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase contrast magnetic resonance flow. Circulation 110: 826-234, 2004.
19. Randall OS, van den Bos GC, and Westerhof N. Systemic compliance: does it play a role in the genesis of essential hypertension? Cardiovasc Res 18: 455-462, 1984.
20. Razavi R, Hill DL, Keevil SF, Miquel ME, Muthurangu V, Hegde S, Rhode K, Barnett M, van Vaals J, Hawkes DJ, and Baker E. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 362: 1877-1882, 2003.
21. Robertson MB, Kohler U, Hoskins PR, and Marshall I. Quantitative analysis of PC MRI velocity maps: pulsatile flow in cylindrical vessels. Magn Reson Imaging 19: 685-695, 2001.
22. Rodes-Cabau J, Domingo E, Roman A, Majo J, Lara B, Padilla F, Anivarro I, Angel J, Tardif JC, and Soler-Soler J. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart 89: 311-315, 2003.
23. Segers P, Brimioulle S, Stergiopulos N, Westerhof N, Naeije R, Maggiorini M, and Verdonck P. Pulmonary arterial compliance in dogs and pigs: the three-element Windkessel model revisited. Am J Physiol Heart Circ Physiol 277: H725-H731, 1999.
24. Slife DM, Latham RD, Sipkema P, and Westerhof N. Pulmonary arterial compliance at rest and exercise in normal humans. Am J Physiol Heart Circ Physiol 258: H1823-H1828, 1990.
25. Sniderman AD and Fitchett DH. Vasodilators and pulmonary arterial hypertension: the paradox of therapeutic success and clinical failure. Int J Cardiol 20: 173-181, 1988.
26. Stenmark KR, Bouchey D, Nemenoff R, Dempsey EC, and Das M. Hypoxia-induced pulmonary vascular remodeling: contribution of the adventitial fibroblasts. Physiol Res 49: 503-517, 2000.
27. Stergiopulos N, Meister JJ, and Westerhof N. Evaluation of methods for estimation of total arterial compliance. Am J Physiol Heart Circ Physiol 268: H1540-H1548, 1995.
28. Stergiopulos N, Meister JJ, and Westerhof N. Simple and accurate way for estimating total and segmental arterial compliance: the pulse pressure method. Ann Biomed Eng 22: 392-397, 1994.
29. Stergiopulos N, Segers P, and Westerhof N. Use of pulse pressure method for estimating total arterial compliance in vivo. Am J Physiol Heart Circ Physiol 276: H424-H428, 1999.
30. Weinberg CE, Hertzberg JR, Ivy DD, Kirby KS, Chan KC, Valdes-Cruz L, and Shandas R. Extraction of pulmonary vascular compliance, pulmonary vascular resistance, and right ventricular work from single-pressure and Doppler flow measurements in children with pulmonary hypertension: a new method for evaluating reactivity: in vitro and clinical studies. Circulation 110: 2609-2617, 2004.